high purity Semaglutide 99% with great price cas 910463-68-2
TDS 1 Inquiries
26447-10-9
Industrial Grade
99%
Shenzhen
subi
5/10/15mg*10vials
2025-07-19
peptone
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCBICertificates
-
TDS
Basic Info-
Product Name:
Ammonium xylenesulfonate
Other Name:Benzenesulfonic acid,dimethyl-,ammonium salt (1:1);Xylenesulfonic acid,ammonium salt;Benzenesulfonic acid,dimethyl-,ammonium salt;Ammonium xylenesulfonate;Cyclophil AXS 40;Stepanate AM;Stepanate AXS;Stepanate AXS 40;127579-57-1
CAS No.:26447-10-9
Molecular Formula:C8H10O3S.H3N
InChIKeys:FGTOZJXFOAPXMR-UHFFFAOYSA-N
Molecular Weight:203.26
Exact Mass:203.06200
EC Number:247-710-9
Categories:
Characteristics-
PSA:
63.8
XLogP3:2.95480
Appearance:Colorless to light yellow liquid, ammonia-like odor.
Boiling Point:403.2ºC at 760 mmHg
Flash Point:197.6ºC
Vapor Pressure:1.35E-05mmHg at 25°C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptone
-
Location:
Room A109, No. 29 Dongting Road, Hexi District, Tianjin
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
3
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2024
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
United States
ammonium xylenesulfonate
50 KG May 20, 2024 Post an enquiry for this product